Pamela Leland
Pamela Leland
1Tumor Vaccines and Biotechnology Branch, Division of Cellular and Gene Therapies, Office of Tissues and Advance Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD 20993 USA
1,
Dhiraj Kumar
Dhiraj Kumar
2Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD USA
2,
Sridhar Nimmagadda
Sridhar Nimmagadda
2Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD USA
2,
Steven R Bauer
Steven R Bauer
1Tumor Vaccines and Biotechnology Branch, Division of Cellular and Gene Therapies, Office of Tissues and Advance Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD 20993 USA
3Present Address: Wake Forest Institute of Regenerative Medicine, Winston Salem, NC USA
1,3,
Raj K Puri
Raj K Puri
1Tumor Vaccines and Biotechnology Branch, Division of Cellular and Gene Therapies, Office of Tissues and Advance Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD 20993 USA
4Present Address: Iovance Biotherapeutics, San Carlos, CA USA
1,4,
Bharat H Joshi
Bharat H Joshi
1Tumor Vaccines and Biotechnology Branch, Division of Cellular and Gene Therapies, Office of Tissues and Advance Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD 20993 USA
1,✉
1Tumor Vaccines and Biotechnology Branch, Division of Cellular and Gene Therapies, Office of Tissues and Advance Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD 20993 USA
2Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD USA
3Present Address: Wake Forest Institute of Regenerative Medicine, Winston Salem, NC USA
4Present Address: Iovance Biotherapeutics, San Carlos, CA USA
© This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2023
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
